Clinical Trials Browser

Glioblastoma, Recurrence

NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

Phase 2/3 Active not recruiting

90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Phase 2/3 Active not recruiting

70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

NCT07366801 2026-01-26

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Phase 2/3 Recruiting

64 enrolled

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03743649 2025-12-26

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

Phase 2/3 Active not recruiting

110 enrolled

Delirium, Neoplasm Metastasis, Recurrence

NCT07198451 2025-09-30

GEM-IR-NMIBC

Phase 2/3 Not yet recruiting

320 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT05595447 2025-03-12

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

Phase 2/3 Recruiting

20 enrolled

Lymphoid

Hodgkin Disease, Recurrence

NCT06241599 2024-02-05

A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2/3 Recruiting

300 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT02634294 2023-03-16

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Phase 2/3 Completed

30 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Recurrence, Hematologic Neoplasms

NCT02673008 2020-02-25

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

Phase 2/3 Completed

206 enrolled

Recurrence, Neoplasm, Residual

NCT00749723 2018-07-20

HIT-REZ-2005

Phase 2/3 Completed

174 enrolled

CNS

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Phase 2/3 Completed

58 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Recurrence

NCT03427034 2018-02-09

ABSEIL

Phase 2/3 Unknown

2,100 enrolled

Genitourinary

Urinary Bladder Neoplasms, Hematuria, Recurrence

NCT03391726 2018-01-05

CCFRRBL

Phase 2/3 Unknown

20 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

NCT01211938 2017-05-16

JANORL2

Phase 2/3 Completed

60 enrolled

Carcinoma, Squamous Cell, Recurrence

NCT01961934 2016-09-28

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Phase 2/3 Withdrawn

CNS

Glioblastoma, Glioma, Recurrence

NCT01423032 2011-08-25

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

Phase 2/3 Completed

96 enrolled

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Phase 2/3 Unknown

290 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00816075 2009-02-17

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

Phase 2/3 Unknown

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

Clinical Trials

GBM AGILE

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

GEM-IR-NMIBC

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

HIT-REZ-2005

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

ABSEIL

CCFRRBL

JANORL2

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection